Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -287,528 | -197,196 | -118,081 | -70,161 | -220,662 |
| Depreciation Amortization | 9,814 | 7,183 | 4,645 | 2,277 | 7,716 |
| Income taxes - deferred | -286 | 884 | 871 | 487 | -185 |
| Accounts receivable | -24,158 | -32,727 | -26,726 | -14,335 | N/A |
| Accounts payable and accrued liabilities | 1,300 | 8,816 | 3,395 | 1,862 | 1,590 |
| Other Working Capital | -51,989 | -52,972 | -40,620 | -17,699 | -23,655 |
| Other Operating Activity | 69,279 | 49,767 | 28,170 | 22,004 | 28,925 |
| Operating Cash Flow | $-283,568 | $-216,245 | $-148,346 | $-75,565 | $-206,271 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 185,590 | 99,932 | 51,888 | -51,304 | -359,733 |
| PPE Investments | -19,043 | -19,928 | -15,520 | -8,243 | -22,075 |
| Purchase Sale Intangibles | -8,089 | -8,089 | N/A | N/A | -12,744 |
| Other Investing Activity | -8,089 | -8,089 | 0 | 0 | -12,744 |
| Investing Cash Flow | $158,458 | $71,915 | $36,368 | $-59,547 | $-394,552 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 550,579 |
| Other Financing Activity | -4,339 | -2,542 | -768 | 0 | 38,975 |
| Financing Cash Flow | $-4,339 | $-2,542 | $-768 | $N/A | $589,554 |
| Exchange Rate Effect | 6,279 | 5,690 | 9,273 | 3,558 | -261 |
| Beginning Cash Position | 228,805 | 228,804 | 228,805 | 228,805 | 240,335 |
| End Cash Position | 105,635 | 87,622 | 125,332 | 97,251 | 228,805 |
| Net Cash Flow | $-123,170 | $-141,182 | $-103,473 | $-131,554 | $-11,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -283,568 | -216,245 | -148,346 | -75,565 | -206,271 |
| Capital Expenditure | -19,043 | -19,928 | -15,520 | -8,243 | -22,075 |
| Free Cash Flow | -302,611 | -236,173 | -163,866 | -83,808 | -228,346 |